Investors are already betting on Nufarm achieving strong growth from its crop protection business, leaving little room for a beat, says Jefferies. It retains a hold call on Nufarm, while lifting its price target by 16% to A$2.58/share. "The Omega-3 growth platform is likely to face another tough year given a glut of supply and depressed pricing, while balance sheet remains full at circa 2x leverage," analyst Ramoun Lazar says. "We see better opportunities in other industrial cyclical names with better returning businesses and less volatile earnings profiles." Nufarm is down 1.7% at A$2.36 early on Wednesday. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
January 20, 2026 18:28 ET (23:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.